Metropolitan Life Insurance Company (MetLife)’s Inseego INSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-541
Closed -$11.2K 2359
2022
Q3
$11.2K Buy
541
+512
+1,766% +$12.4K ﹤0.01% 2266
2022
Q2
$542 Sell
29
-502
-95% -$12.8K ﹤0.01% 2367
2022
Q1
$21.5K Sell
531
-637
-55% -$29.1K ﹤0.01% 2056
2021
Q4
$68.1K Sell
1,168
-273
-19% -$17.7K ﹤0.01% 2650
2021
Q3
$95.9K Sell
1,441
-612
-30% -$51.2K ﹤0.01% 2546
2021
Q2
$207K Buy
2,053
+252
+14% +$23K ﹤0.01% 2112
2021
Q1
$180K Sell
1,801
-171
-9% -$24.9K ﹤0.01% 2092
2020
Q4
$305K Buy
1,972
+379
+24% +$41.9K ﹤0.01% 1671
2020
Q3
$164K Sell
1,593
-534
-25% -$61.6K ﹤0.01% 1904
2020
Q2
$247K Buy
2,127
+1,310
+160% +$139K ﹤0.01% 1664
2020
Q1
$50.9K Buy
817
+117
+17% +$8.44K ﹤0.01% 2377
2019
Q4
$51.3K Sell
700
-840
-55% -$48.5K ﹤0.01% 2496
2019
Q3
$73.9K Buy
+1,540
New +$71.6K ﹤0.01% 2448

Other funds holding INSG

Metropolitan Life Insurance Company (MetLife)'s INSG Position: Q4 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Inseego (INSG) in Q4 2022, closing a stake of 541 shares — an estimated $11.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INSG in Q3 2019 and held it in 13 quarters. The position peaked at $305K in Q4 2020. 131 funds tracked by Wall St. Rank hold INSG as of Q4 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Inseego position as of Q4 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 541 Inseego shares in Q4 2022, an estimated $11.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Inseego in Q3 2019 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Inseego position peaked at $305K in Q4 2020.
  • 131 funds tracked by Wall St. Rank held Inseego as of Q4 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.